Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations
Acta Neuropathologica · 2023-12 · 146 (6) · 849-852
DOI: 10.1007/s00401-023-02640-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Neuropathologica, online erschienen am 18.10.2023. Verfasst von Holly J Roberts und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Michigan Medicine, Ann Arbor, MI, USA. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioma. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHGRI NIH HHS, NCI NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pediatrics, Michigan Medicine, Ann Arbor, MI, USA.
- Department of Neurology-2, Pitié-Salpêtrière University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
- Onconeurotek, AP-HP, Hôpital Pitié-Salpêtrière, 75013, Paris, France.
- Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle Épinière, ICM, Paris, France.
- Department of Neurology, NYU Langone Health, New York, NY, USA.
- Department of Pathology, NYU Langone Health, New York, NY, USA.
ORCID-Profile: Carl Koschmann
Förderung
- NHGRI NIH HHS
- NCI NIH HHS
- NINDS NIH HHS
- NHLBI NIH HHS
- Foundation for the National Institutes of Health
- U.S. Department of Defense
- University of Michigan Chad Carr Pediatric Brain Tumor Center
- The Evans Family
Zitieren
APA
Roberts, H. J., Ji, S., Picca, A., Sanson, M., Garcia, M., Snuderl, M., Schüller, U., Picart, T., Ducray, F., Green, A. L., Nakano, Y., Sturm, D., Abdullaev, Z., Aldape, K., Dang, D., Kumar-Sinha, C., Wu, Y. M., Robinson, D., Vo, J. N., …, & Koschmann, C. (2023). Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations. Acta Neuropathologica, 146(6), 849-852. https://doi.org/10.1007/s00401-023-02640-7
Vancouver
Roberts HJ, Ji S, Picca A, Sanson M, Garcia M, Snuderl M, et al. Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations. Acta Neuropathologica. 2023;146(6):849-852. doi:10.1007/s00401-023-02640-7
BibTeX
@article{Roberts2023,
author = {Roberts, Holly J and Ji, Sunjong and Picca, Alberto and Sanson, Marc and Garcia, Mekka and Snuderl, Matija and Schüller, Ulrich and Picart, Thiébaud and Ducray, François and Green, Adam L and Nakano, Yoshiko and Sturm, Dominik and Abdullaev, Zied and Aldape, Kenneth and Dang, Derek and Kumar-Sinha, Chandan and Wu, Yi-Mi and Robinson, Dan and Vo, Josh N and Chinnaiyan, Arul M and Cartaxo, Rodrigo and Upadhyaya, Santhosh A and Mody, Rajen and Chiang, Jason and Baker, Suzanne and Solomon, David and Venneti, Sriram and Pratt, Drew and Waszak, Sebastian M and Koschmann, Carl},
title = {Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations},
journal = {Acta Neuropathologica},
year = {2023},
volume = {146},
number = {6},
pages = {849--852},
doi = {10.1007/s00401-023-02640-7}
}
EUVIMED